Sandoz Among Defeated As US Federal Circuit Breathes New Life Into US Myrbetriq Patent
US District Court ‘Abused Its Discretion’ In Earlier Overturning Mirabegron IP
A US district court “misapprehended its role in adjudicating the issue of patentability,” the US Federal Circuit found, as it vacated and remanded the lower court’s US patent invalidity decision, raising fresh questions in a market that has already seen generic launches from a pair of manufacturers.
